FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, specifically to a novel derivative of an insulin analogue, and can be used in medicine. Invention allows to obtain an insulin derivative with a long pharmacokinetic profile, which enables the derivative to be used in the treatment of patients suffering from diabetes, with the use of more rare injections of a drug based on such a derivative.
EFFECT: novel derivative of an insulin analogue is disclosed.
10 cl, 17 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN ANALOGUES WITH ACYL AND ALKYLENE GLYCOL GROUP | 2008 |
|
RU2514430C2 |
| INSULIN DERIVATIVES CONTAINING ADDITIONAL DISULFIDE BONDS | 2011 |
|
RU2598273C2 |
| NOVEL INSULIN DERIVATIVES AND USE THEREOF | 2015 |
|
RU2684456C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING INSULIN | 2017 |
|
RU2758367C2 |
| ACYLATED INSULIN ANALOGUES STABILISED WITH RESPECT TO PROTEASES | 2009 |
|
RU2571857C2 |
| PROTEASE-RESISTANT INSULIN ANALOGUES | 2007 |
|
RU2524150C2 |
| INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
| STABLE COMPOSITION OF INSULIN GLULISIN | 2014 |
|
RU2691059C2 |
| RAPIDLY FIXED DOSAGE FORMS OF INSULIN | 2010 |
|
RU2506945C2 |
| COMPLEX OF INSULIN ANALOG AND PROTAMINE, METHOD OF PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD OF DIABETIC TREATMENT | 1995 |
|
RU2154494C2 |
